DaVita Total Long Term Liabilities 2010-2024 | DVA

DaVita total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • DaVita total long term liabilities for the quarter ending September 30, 2024 were $13.973B, a 7.39% increase year-over-year.
  • DaVita total long term liabilities for 2023 were $13.007B, a 3.17% decline from 2022.
  • DaVita total long term liabilities for 2022 were $13.433B, a 2.57% decline from 2021.
  • DaVita total long term liabilities for 2021 were $13.787B, a 6.5% increase from 2020.
DaVita Annual Total Long Term Liabilities
(Millions of US $)
2023 $13,007
2022 $13,433
2021 $13,787
2020 $12,946
2019 $12,620
2018 $10,311
2017 $11,021
2016 $11,195
2015 $11,032
2014 $10,168
2013 $10,031
2012 $10,081
2011 $5,471
2010 $5,153
2009 $4,317
DaVita Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $13,973
2024-06-30 $13,181
2024-03-31 $13,715
2023-12-31 $13,007
2023-09-30 $13,012
2023-06-30 $13,349
2023-03-31 $13,143
2022-12-31 $13,433
2022-09-30 $13,722
2022-06-30 $14,015
2022-03-31 $13,648
2021-12-31 $13,787
2021-09-30 $13,943
2021-06-30 $13,961
2021-03-31 $13,899
2020-12-31 $12,946
2020-09-30 $12,794
2020-06-30 $12,697
2020-03-31 $13,242
2019-12-31 $12,620
2019-09-30 $12,733
2019-06-30 $9,981
2019-03-31 $10,288
2018-12-31 $10,311
2018-09-30 $10,473
2018-06-30 $10,167
2018-03-31 $11,213
2017-12-31 $11,021
2017-09-30 $11,169
2017-06-30 $11,297
2017-03-31 $11,234
2016-12-31 $11,195
2016-09-30 $11,167
2016-06-30 $11,087
2016-03-31 $11,149
2015-12-31 $11,032
2015-09-30 $11,292
2015-06-30 $11,266
2015-03-31 $10,516
2014-12-31 $10,168
2014-09-30 $10,352
2014-06-30 $10,361
2014-03-31 $9,995
2013-12-31 $10,031
2013-09-30 $9,937
2013-06-30 $9,958
2013-03-31 $10,132
2012-12-31 $10,081
2012-09-30 $6,817
2012-06-30 $5,511
2012-03-31 $5,513
2011-12-31 $5,471
2011-09-30 $5,418
2011-06-30 $5,211
2011-03-31 $5,179
2010-12-31 $5,153
2010-09-30 $4,139
2010-06-30 $4,102
2010-03-31 $4,326
2009-12-31 $4,317
2009-09-30 $4,286
2009-06-30 $4,276
2009-03-31 $4,285
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.872B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00